0,"{'STD-Aaes_x002d_Jorgensen-1981b': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
1,"{'STD-Addington-2004': array([ '../ALL-2015-06/Q-Z/Ziprasidone versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
2,"{'STD-Adson-2003': array([ '../ALL-2015-06/A-B/Aripiprazole versus placebo for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
3,"{'STD-Albert-1980': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
4,"{'STD-Amin-1977': array([ '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
5,"{'STD-Andrews-1976': array([ '../ALL-2015-06/C-F/Cessation of medication for people with schizophrenia already stable on chlorpromazine [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
6,"{'STD-Atmaca-2003': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
7,"{'STD-Azorin-2001': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
8,"{'STD-Azorin-2006': array([ '../ALL-2015-06/Q-Z/Sertindole versus other atypical antipsychotics for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
9,"{'STD-Bagadia-1980': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
10,"{'STD-Bai-2005': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
11,"{'STD-Balasubramanian-1991': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
12,"{'STD-Ban-1975': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
13,"{'STD-Barnes-1983': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5'], dtype=object)}"
14,"{'STD-Barrowclough-2001': array([ '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Psychosocial interventions for people with both severe mental illness and substance misuse [v10.2-For publication].rm5'], dtype=object)}"
15,"{'STD-Battaglia-1997': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
16,"{'STD-Bechdolf-2004': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
17,"{'STD-Bechelli-1983': array([ '../ALL-2015-06/G-P/Haloperidol versus placebo for schizophrenia [v13.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
18,"{'STD-Bechelli-1985': array([ '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
19,"{'STD-Bi-1994': array([ '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
20,"{'STD-Bishop-1963': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
21,"{'STD-Bishop-1970': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
22,"{'STD-Bitter-2004': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
23,"{'STD-Blanco-1972': array([ '../ALL-2015-06/Q-Z/Sulpiride versus placebo for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Sulpiride for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
24,"{'STD-Blin-1996': array([ '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus typical antipsychotic medication for schizophrenia [v12.0-For publication].rm5'], dtype=object)}"
25,"{'STD-Bond_x002d_Chicago1': array([ '../ALL-2015-06/G-P/Intensive case management for severe mental illness [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Vocational rehabilitation for people with severe mental illness [v6.0-For publication].rm5'], dtype=object)}"
26,"{'STD-Bondolfi-1998': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
27,"{'STD-Bonsack-2011': array([ '../ALL-2015-06/C-F/Cannabis and schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Psychosocial interventions for people with both severe mental illness and substance misuse [v10.2-For publication].rm5'], dtype=object)}"
28,"{'STD-Borison-1989': array([ '../ALL-2015-06/G-P/Haloperidol versus placebo for schizophrenia [v13.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
29,"{'STD-Borison-1991': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus typical antipsychotic medication for schizophrenia [v12.0-For publication].rm5'], dtype=object)}"
30,"{'STD-Bradley-2006': array([ '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
31,"{'STD-Brauzer-1971': array([ '../ALL-2015-06/G-P/Molindone for schizophrenia and severe mental illness [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
32,"{'STD-Breier-1999': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
33,"{'STD-Breier-2005': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Ziprasidone versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
34,"{'STD-Buchkremer-1997': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
35,"{'STD-CATIE-2005': array([ '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
36,"{'STD-Caffey-1964': array([ '../ALL-2015-06/C-F/Cessation of medication for people with schizophrenia already stable on chlorpromazine [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
37,"{'STD-Canive-2000': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
38,"{'STD-Carson-2000-a': array([ '../ALL-2015-06/A-B/Aripiprazole versus placebo for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
39,"{'STD-Carson-2002-b': array([ '../ALL-2015-06/A-B/Aripiprazole versus placebo for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
40,"{'STD-Casey-2003': array([ '../ALL-2015-06/A-B/Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems [v4.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
41,"{'STD-Cassano-1975': array([ '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Sulpiride for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
42,"{'STD-Cather-2005': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
43,"{'STD-Chan-2003': array([ '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
44,"{'STD-Chan-2007': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
45,"{'STD-Chen-2003': array([ '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
46,"{'STD-Chen-2009': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/G-P/Life skills programmes for chronic mental illnesses [v10.0-For publication].rm5'], dtype=object)}"
47,"{'STD-Chen-2010': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
48,"{'STD-Cheung-1981': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
49,"{'STD-Chien-2004': array([ '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
50,"{'STD-Chouinard-1978': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
51,"{'STD-Chouinard-1982': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5'], dtype=object)}"
52,"{'STD-Chouinard-1984': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
53,"{'STD-Chouinard-1993': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus placebo for schizophrenia [v13.0-For publication].rm5'], dtype=object)}"
54,"{'STD-Claghorn-1974': array([ '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
55,"{'STD-Clark-1969': array([ '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
56,"{'STD-Clark-1971': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
57,"{'STD-Clark-1972': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/C-F/Chlorpromazine dose for people with schizophrenia [v3.0-For publication].rm5',
       '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
58,"{'STD-Clark-1975': array([ '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5',
       '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
59,"{'STD-Clark-1977': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
60,"{'STD-Cole-1964': array([ '../ALL-2015-06/A-B/Antipsychotic medication for early episode schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5'], dtype=object)}"
61,"{'STD-Conley-2001': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
62,"{'STD-Conley-2003': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
63,"{'STD-Conley-2005': array([ '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
64,"{'STD-Cookson-1986': array([ '../ALL-2015-06/A-B/Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems [v4.0-For publication].rm5',
       '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
65,"{'STD-Coons-1962': array([ '../ALL-2015-06/Q-Z/Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
66,"{'STD-Cooper-2000': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
67,"{'STD-Csernansky-2003': array([ '../ALL-2015-06/A-B/Aripiprazole versus typical antipsychotic drugs for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole versus placebo for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
68,"{'STD-Daniel-2000': array([ '../ALL-2015-06/A-B/Aripiprazole versus typical antipsychotic drugs for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole versus placebo for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
69,"{'STD-Daniel-2004': array([ '../ALL-2015-06/A-B/Aripiprazole versus typical antipsychotic drugs for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole versus placebo for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
70,"{'STD-Dehnel-1968': array([ '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
71,"{'STD-Dencker-1973': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
72,"{'STD-Denijs-1973': array([ '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
73,"{'STD-Dieterle-1991': array([ '../ALL-2015-06/G-P/Perazine for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Zotepine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
74,"{'STD-Dollfus-2005': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
75,"{'STD-Dolnak-2001': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
76,"{'STD-Dorevitch-1999': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
77,"{'STD-Drury-2000': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
78,"{'STD-Dufresne-1993': array([ '../ALL-2015-06/G-P/Molindone for schizophrenia and severe mental illness [v4.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
79,"{'STD-Durham-2003': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Supportive therapy for schizophrenia [v7.2-For publication].rm5'], dtype=object)}"
80,"{'STD-Eberhard-1986': array([ '../ALL-2015-06/C-F/Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders [v4.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
81,"{'STD-Eckmann-1984': array([ '../ALL-2015-06/A-B/Benperidol for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5'], dtype=object)}"
82,"{'STD-Edwards-1980': array([ '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Sulpiride for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
83,"{'STD-Edwards-2006': array([ '../ALL-2015-06/C-F/Cannabis and schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Psychosocial interventions for people with both severe mental illness and substance misuse [v10.2-For publication].rm5'], dtype=object)}"
84,"{'STD-Eklund-1991': array([ '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
85,"{'STD-Emsley-2006': array([ '../ALL-2015-06/G-P/Polyunsaturated fatty acid supplementation for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/G-P/Miscellaneous treatments for neuroleptic-induced tardive dyskinesia [v11.0-For publication].rm5'], dtype=object)}"
86,"{'STD-Escobar-1985': array([ '../ALL-2015-06/G-P/Molindone for schizophrenia and severe mental illness [v4.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
87,"{'STD-Falloon-1978': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5'], dtype=object)}"
88,"{'STD-Fischer-1976': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
89,"{'STD-Foster-1997': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
90,"{'STD-Freeman-1962': array([ '../ALL-2015-06/C-F/Cessation of medication for people with schizophrenia already stable on chlorpromazine [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
91,"{'STD-Fruensgaard-1977': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
92,"{'STD-Fruensgaard-1978': array([ '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5',
       '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
93,"{'STD-Galderisi-1994': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
94,"{'STD-Gallant-1967': array([ '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
95,"{'STD-Gallant-1968': array([ '../ALL-2015-06/G-P/Molindone for schizophrenia and severe mental illness [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
96,"{'STD-Gallant-1972': array([ '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
97,"{'STD-Garety-2008': array([ '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
98,"{'STD-Garza_x002d_Trevino-1989': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
99,"{'STD-Glazer-1990': array([ '../ALL-2015-06/G-P/Molindone for schizophrenia and severe mental illness [v4.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
100,"{'STD-Goldstein-1978': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5'], dtype=object)}"
101,"{'STD-Gowardman-1973': array([ '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
102,"{'STD-Gravem-1978': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
103,"{'STD-Gravem-1981': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
104,"{'STD-Gross-1974': array([ '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
105,"{'STD-Guo-2007': array([ '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
106,"{'STD-Gureje-2003': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
107,"{'STD-Gwynne-1962': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
108,"{'STD-Haas-1982': array([ '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
109,"{'STD-Haddock-1999': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Supportive therapy for schizophrenia [v7.2-For publication].rm5'], dtype=object)}"
110,"{'STD-Haddock-2009': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
111,"{'STD-Hankoff-1962': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5'], dtype=object)}"
112,"{'STD-Hanlon-1965': array([ '../ALL-2015-06/G-P/Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5'], dtype=object)}"
113,"{'STD-Heikkila-1981a': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
114,"{'STD-Heikkila-1981b': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
115,"{'STD-Heikkila-1992': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
116,"{'STD-Heinrich-1994': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
117,"{'STD-Herz-2000': array([ '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
118,"{'STD-Hjorthoj-2013': array([ '../ALL-2015-06/C-F/Cannabis and schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Psychosocial interventions for people with both severe mental illness and substance misuse [v10.2-For publication].rm5'], dtype=object)}"
119,"{'STD-Hogarty-1973': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
120,"{'STD-Howard-1974': array([ '../ALL-2015-06/G-P/Haloperidol versus placebo for schizophrenia [v13.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
121,"{'STD-Hoyberg-1993': array([ '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus typical antipsychotic medication for schizophrenia [v12.0-For publication].rm5'], dtype=object)}"
122,"{'STD-Huttunen-1995': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus typical antipsychotic medication for schizophrenia [v12.0-For publication].rm5'], dtype=object)}"
123,"{'STD-Hwang-2003': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
124,"{'STD-Itoh-1969': array([ '../ALL-2015-06/C-F/Clotiapine for acute psychotic illnesses [v10.0-Unmarked for publication 8 Oct 2012].rm5',
       '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5'], dtype=object)}"
125,"{'STD-Jackson-2008': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
126,"{'STD-Jain-1975': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
127,"{'STD-Javed-1991': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders [v4.0-For publication].rm5'], dtype=object)}"
128,"{'STD-Jeste-2003': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
129,"{'STD-Kane-2003': array([ '../ALL-2015-06/A-B/Aripiprazole versus typical antipsychotic drugs for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5'], dtype=object)}"
130,"{'STD-Kane-2005': array([ '../ALL-2015-06/Q-Z/Sertindole versus other atypical antipsychotics for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
131,"{'STD-Keefe-2006': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
132,"{'STD-Kelly-1977': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders [v4.0-For publication].rm5'], dtype=object)}"
133,"{'STD-Kemp-1998': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
134,"{'STD-Kern-2001': array([ '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5'], dtype=object)}"
135,"{'STD-Kiloh-1976': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
136,"{'STD-Kingstone-1970': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
137,"{'STD-Kinon-2006b': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
138,"{'STD-Kissling-1985': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
139,"{'STD-Klimke-1993': array([ '../ALL-2015-06/G-P/Perazine for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5'], dtype=object)}"
140,"{'STD-Klingberg-2009': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
141,"{'STD-Kordas-1968': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
142,"{'STD-Krakowski-2006': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
143,"{'STD-Kramer-1978': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
144,"{'STD-Kramer-2007': array([ '../ALL-2015-06/G-P/Oral paliperidone for schizophrenia [v8.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
145,"{'STD-Kujawa-2002': array([ '../ALL-2015-06/A-B/Aripiprazole versus typical antipsychotic drugs for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
146,"{'STD-Kumra-2008': array([ '../ALL-2015-06/A-B/Atypical antipsychotics for psychosis in adolescents [v2.0-For publication].rm5',
       '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
147,"{'STD-Kurihara-1983': array([ '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
148,"{'STD-Kurland-1961': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5'], dtype=object)}"
149,"{'STD-Kurland-1966': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
150,"{'STD-Lecrubier-2006': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
151,"{'STD-Leff-1971': array([ '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5'], dtype=object)}"
152,"{'STD-Leong-1989': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
153,"{'STD-Lepola-1989': array([ '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Sulpiride for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
154,"{'STD-Levine-1998': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Supportive therapy for schizophrenia [v7.2-For publication].rm5'], dtype=object)}"
155,"{'STD-Lewis-2002': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
156,"{'STD-Lewis-2002-_x002d_-Liverpool': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
157,"{'STD-Lewis-2002-_x002d_-Manchester': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
158,"{'STD-Lewis-2002-_x002d_-Nottingham': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
159,"{'STD-Li--2005': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
160,"{'STD-Li-2003': array([ '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
161,"{'STD-Li-2004': array([ '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Pharmacological interventions for clozapine-induced hypersalivation [v6.0-For publication].rm5',
       '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
162,"{'STD-Li-2005a': array([ '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
163,"{'STD-Li-2006': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
164,"{'STD-Li-2007': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/G-P/Music therapy for people with schizophrenia and schizophrenia-like disorders [v7.0-For publication].rm5'], dtype=object)}"
165,"{'STD-Lieberman-2005': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Ziprasidone versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
166,"{'STD-Lin-2003': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Zotepine versus other atypical antipsychotics for schizophrenia [v8.0-For publication].rm5'], dtype=object)}"
167,"{'STD-Littrell-1999': array([ '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
168,"{'STD-Liu-2000': array([ '../ALL-2015-06/C-F/Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus typical antipsychotic medication for schizophrenia [v12.0-For publication].rm5'], dtype=object)}"
169,"{'STD-Liu-2007': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5'], dtype=object)}"
170,"{'STD-Lundin-1990': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders [v4.0-For publication].rm5'], dtype=object)}"
171,"{'STD-M_x00f6_ller-2005': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
172,"{'STD-Mahadevan-1991': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Sulpiride for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
173,"{'STD-Malik-1980': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
174,"{'STD-Malyarov-1999': array([ '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus typical antipsychotic medication for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
175,"{'STD-Man-1973': array([ '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
176,"{'STD-Marcus-2005': array([ '../ALL-2015-06/A-B/Aripiprazole versus placebo for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
177,"{'STD-Marder-1994': array([ '../ALL-2015-06/G-P/Haloperidol versus placebo for schizophrenia [v13.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus typical antipsychotic medication for schizophrenia [v12.0-For publication].rm5'], dtype=object)}"
178,"{'STD-Marjerrison-1964': array([ '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
179,"{'STD-May-1976': array([ '../ALL-2015-06/A-B/Antipsychotic medication for early episode schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness [v10.0-For publication].rm5'], dtype=object)}"
180,"{'STD-Mayang-1990': array([ '../ALL-2015-06/G-P/Problem solving skills for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Social skills programmes for schizophrenia [v4.8-For publication].rm5'], dtype=object)}"
181,"{'STD-McCreadie-1977': array([ '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
182,"{'STD-McCreadie-1980': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5'], dtype=object)}"
183,"{'STD-McEvoy-2006': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
184,"{'STD-McEvoy-2007': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
185,"{'STD-McGurk-2005': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
186,"{'STD-McKane-1987': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
187,"{'STD-McLaren-1992': array([ '../ALL-2015-06/A-B/Bromperidol decanoate (depot) for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
188,"{'STD-McQuade-2003': array([ '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5'], dtype=object)}"
189,"{'STD-McQuade-2004': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
190,"{'STD-Meltzer-2003': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
191,"{'STD-Merinder-1999': array([ '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
192,"{'STD-Moresco-2004': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
193,"{'STD-Mori-2004': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
194,"{'STD-Mortimer-2004': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
195,"{'STD-Morton-1968': array([ '../ALL-2015-06/C-F/Cessation of medication for people with schizophrenia already stable on chlorpromazine [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5'], dtype=object)}"
196,"{'STD-Naber-2005': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
197,"{'STD-Namjoshi-2002': array([ '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
198,"{'STD-Nishikawa-1982': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus placebo for schizophrenia [v13.0-For publication].rm5'], dtype=object)}"
199,"{'STD-Nishikawa-1984': array([ '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus placebo for schizophrenia [v13.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
200,"{'STD-Nishikawa-1985': array([ '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
201,"{'STD-Nishizono-1994': array([ '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
202,"{'STD-O_x0027_Donnell-2003': array([ '../ALL-2015-06/C-F/Compliance therapy for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
203,"{'STD-Odejide-1982': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
204,"{'STD-Olie-2006': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Ziprasidone versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
205,"{'STD-Oren-2005': array([ '../ALL-2015-06/A-B/Aripiprazole versus typical antipsychotic drugs for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole versus placebo for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
206,"{'STD-Ozguven-2004': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
207,"{'STD-Papageorgiou-2002': array([ '../ALL-2015-06/A-B/Advance treatment directives for people with severe mental illness [v8.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/User-held personalised information for routine care of people with severe mental illness [v7.3-For publication].rm5'], dtype=object)}"
208,"{'STD-Peng-2007': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
209,"{'STD-Penn-2009': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Supportive therapy for schizophrenia [v7.2-For publication].rm5'], dtype=object)}"
210,"{'STD-Perales-1974': array([ '../ALL-2015-06/C-F/Clotiapine for acute psychotic illnesses [v10.0-Unmarked for publication 8 Oct 2012].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
211,"{'STD-Peuskens-1999': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/A-B/Amisulpride for schizophrenia [v11.3-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
212,"{'STD-Pinto-1979': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders [v4.0-For publication].rm5'], dtype=object)}"
213,"{'STD-Pinto-1999': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Supportive therapy for schizophrenia [v7.2-For publication].rm5'], dtype=object)}"
214,"{'STD-Pool-1976': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
215,"{'STD-Potkin-2003': array([ '../ALL-2015-06/A-B/Aripiprazole versus placebo for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
216,"{'STD-Potkin-2006': array([ '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
217,"{'STD-Prien-1968': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/C-F/Chlorpromazine dose for people with schizophrenia [v3.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
218,"{'STD-Prien-1969': array([ '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
219,"{'STD-Purdon-2000': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus typical antipsychotic medication for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
220,"{'STD-R_x00fc_ther-1988': array([ '../ALL-2015-06/A-B/Amisulpride for schizophrenia [v11.3-For publication].rm5',
       '../ALL-2015-06/G-P/Perazine for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
221,"{'STD-Rama-Rao-1981': array([ '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Sulpiride for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
222,"{'STD-Ramsay-1970': array([ '../ALL-2015-06/G-P/Molindone for schizophrenia and severe mental illness [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
223,"{'STD-Ramu-1999': array([ '../ALL-2015-06/A-B/Ayurvedic medicine for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5'], dtype=object)}"
224,"{'STD-Rappaport-1978': array([ '../ALL-2015-06/A-B/Antipsychotic medication for early episode schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5'], dtype=object)}"
225,"{'STD-Reardon-1966': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
226,"{'STD-Remvig-1987': array([ '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
227,"{'STD-Ren-2002': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
228,"{'STD-Reschke-1974': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
229,"{'STD-Riedel-2005': array([ '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
230,"{'STD-Riedel-2007': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
231,"{'STD-Ritchie-2003': array([ '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
232,"{'STD-Ritter-1972': array([ '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
233,"{'STD-Rompel-1978': array([ '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
234,"{'STD-Rossi-1990': array([ '../ALL-2015-06/A-B/Bromperidol decanoate (depot) for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
235,"{'STD-Rubin-1971': array([ '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
236,"{'STD-Sacchetti-2004': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
237,"{'STD-Sacchetti-2006': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Ziprasidone versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
238,"{'STD-Schiele-1961': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
239,"{'STD-Schlosberg-1978': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
240,"{'STD-Schmidt-1982': array([ '../ALL-2015-06/G-P/Perazine for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5'], dtype=object)}"
241,"{'STD-Schneider-1981': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
242,"{'STD-Schooler-1997': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5'], dtype=object)}"
243,"{'STD-Sechter-2002': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
244,"{'STD-Selman-1976': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus placebo for schizophrenia [v13.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
245,"{'STD-Sensky-2000': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
246,"{'STD-Serafetinides-1972': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus placebo for schizophrenia [v13.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
247,"{'STD-Seth-1979': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
248,"{'STD-Shalev-1993': array([ '../ALL-2015-06/G-P/Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
249,"{'STD-Shaw-2006': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
250,"{'STD-Shawver-1959': array([ '../ALL-2015-06/C-F/Cessation of medication for people with schizophrenia already stable on chlorpromazine [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
251,"{'STD-Shiloh-1997': array([ '../ALL-2015-06/Q-Z/Sulpiride for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Sulpiride augmentation for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
252,"{'STD-Sikich-2004': array([ '../ALL-2015-06/A-B/Atypical antipsychotics for psychosis in adolescents [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
253,"{'STD-Silverstone-1984': array([ '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
254,"{'STD-Simon-1978': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
255,"{'STD-Simpson-1976': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
256,"{'STD-Simpson-2004': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Ziprasidone versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
257,"{'STD-Singh-1979': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
258,"{'STD-Sirota-2006': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
259,"{'STD-Somerville-1960': array([ '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
260,"{'STD-Song-2008': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
261,"{'STD-Soni-1990': array([ '../ALL-2015-06/Q-Z/Sulpiride versus placebo for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Sulpiride for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
262,"{'STD-Steinert-1986': array([ '../ALL-2015-06/C-F/Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders [v4.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
263,"{'STD-Sterlin-1972': array([ '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol dihydrochloride for schizophrenia [v5.0-For publication].rm5'], dtype=object)}"
264,"{'STD-Stewart-1969': array([ '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
265,"{'STD-Stroup-2006': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Ziprasidone versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
266,"{'STD-Svestka-2003': array([ '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
267,"{'STD-Svestka-2003b': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
268,"{'STD-Svestka-2005': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Ziprasidone versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
269,"{'STD-Tarrier-1993': array([ '../ALL-2015-06/C-F/Distraction techniques for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/G-P/Problem solving skills for schizophrenia [v10.0-For publication].rm5'], dtype=object)}"
270,"{'STD-Teja-1975': array([ '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus chlorpromazine for schizophrenia [v9.0-For publication].rm5'], dtype=object)}"
271,"{'STD-Tollefson-2001': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
272,"{'STD-Tran-1997': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
273,"{'STD-Tran-1997-_x0028_HGBG_x0029_': array([ '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
274,"{'STD-Tuason-1986': array([ '../ALL-2015-06/G-P/Loxapine for schizophrenia [v10.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) [v2.3-For publication].rm5'], dtype=object)}"
275,"{'STD-Turkington-2000': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Supportive therapy for schizophrenia [v7.2-For publication].rm5'], dtype=object)}"
276,"{'STD-Valmaggia-2005': array([ '../ALL-2015-06/C-F/Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia [v5.0-For publication] (1).rm5',
       '../ALL-2015-06/C-F/Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia [v11.0-For publication].rm5'], dtype=object)}"
277,"{'STD-Van-Nimwegen-2006': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
278,"{'STD-Vanelle-2006': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
279,"{'STD-Vergara-1977': array([ '../ALL-2015-06/G-P/Pimozide for schizophrenia or related psychoses [v10.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Trifluoperazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
280,"{'STD-Volavka-2002': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
281,"{'STD-Voruganti-2007': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
282,"{'STD-Wagner-2005': array([ '../ALL-2015-06/A-B/Amisulpride versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
283,"{'STD-Wahlbeck-2000': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
284,"{'STD-Wang-1994': array([ '../ALL-2015-06/G-P/Morita therapy for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Sulpiride augmentation for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
285,"{'STD-Wang-2000': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/G-P/Morita therapy for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
286,"{'STD-Wang-2002': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/G-P/Morita therapy for schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
287,"{'STD-Wang-2003': array([ '../ALL-2015-06/A-B/Benzodiazepines for schizophrenia [v5.4-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5'], dtype=object)}"
288,"{'STD-Wang-2005': array([ '../ALL-2015-06/A-B/Aripiprazole versus typical antipsychotic drugs for schizophrenia [v7.0-For publication].rm5',
       '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5'], dtype=object)}"
289,"{'STD-Wang-2006': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
290,"{'STD-Wang-2008c': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5'], dtype=object)}"
291,"{'STD-Weston-1973': array([ '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Thioridazine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
292,"{'STD-Wetzel-1991': array([ '../ALL-2015-06/G-P/Perazine for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Zotepine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
293,"{'STD-White-1981': array([ '../ALL-2015-06/G-P/Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia [v2.0-For publication].rm5',
       '../ALL-2015-06/G-P/Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders [v2.2-For publication].rm5'], dtype=object)}"
294,"{'STD-Wistedt-1983': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders [v4.0-For publication].rm5'], dtype=object)}"
295,"{'STD-Wistedt-1984': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
296,"{'STD-Wistedt-1991': array([ '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses [v5.0-For publication].rm5'], dtype=object)}"
297,"{'STD-Woggon-1977': array([ '../ALL-2015-06/C-F/Fluphenazine decanoate (depot) and enanthate for schizophrenia [v9.0-For publication].rm5',
       '../ALL-2015-06/C-F/Depot pipotiazine palmitate and undecylenate for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
298,"{'STD-Wolkin-1986': array([ '../ALL-2015-06/G-P/Polyunsaturated fatty acid supplementation for schizophrenia [v11.0-For publication].rm5',
       '../ALL-2015-06/G-P/Miscellaneous treatments for neuroleptic-induced tardive dyskinesia [v11.0-For publication].rm5'], dtype=object)}"
299,"{'STD-Wynn-2007': array([ '../ALL-2015-06/G-P/Olanzapine versus other atypical antipsychotics for schizophrenia [v6.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
300,"{'STD-Xiong-1994': array([ '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/C-F/Chlorpromazine versus placebo for schizophrenia [v14.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Training to recognise the early signs of recurrence in schizophrenia [v6.0-For publication].rm5'], dtype=object)}"
301,"{'STD-Zhang-2006a': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5'], dtype=object)}"
302,"{'STD-Zhang-2010': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/G-P/Perphenazine for schizophrenia [v6.2-For publication].rm5'], dtype=object)}"
303,"{'STD-Zhao-2007': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/G-P/Life skills programmes for chronic mental illnesses [v10.0-For publication].rm5'], dtype=object)}"
304,"{'STD-Zhong-2006': array([ '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Quetiapine versus other atypical antipsychotics for schizophrenia [v4.2-For publication].rm5'], dtype=object)}"
305,"{'STD-Zhou-2000': array([ '../ALL-2015-06/C-F/Clozapine versus other atypical antipsychotics for schizophrenia [v5.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus other atypical antipsychotics for schizophrenia [v4.0-For publication].rm5'], dtype=object)}"
306,"{'STD-Zhou-2007': array([ '../ALL-2015-06/A-B/Aripiprazole versus other atypical antipsychotics for schizophrenia [v6.7-For publication].rm5',
       '../ALL-2015-06/C-F/Family intervention for schizophrenia [v14.0-For publication].rm5'], dtype=object)}"
307,"{'STD-Zissis-1982': array([ '../ALL-2015-06/C-F/Depot haloperidol decanoate for schizophrenia [v4.0-For publication].rm5',
       '../ALL-2015-06/G-P/Maintenance treatment with antipsychotic drugs for schizophrenia [v3.2-For publication].rm5'], dtype=object)}"
308,"{'STD-de-Haan-2002': array([ '../ALL-2015-06/G-P/Olanzapine for schizophrenia [v12.0-For publication].rm5',
       '../ALL-2015-06/Q-Z/Risperidone versus olanzapine for schizophrenia [v7.0-For publication].rm5'], dtype=object)}"
